Alnylam Provides Details on Preclinical Neurology Programs at Society for Neuroscience Meeting

/Home/Biologics Delivery - Protein Synthesis/RNA - Protein Synthesis/RNAi - Protein Synthesis

Alnylam Provides Details on Preclinical Neurology Programs at Society for Neuroscience Meeting
By Doug Macron
October 19, 2006
RNAi News
The company provided new details about its preclinical work in Huntington?s disease, neuropathic pain, Parkinson?s disease, and dystonia ? although none of these programs are in the company?s official development pipeline.
Paid subscription is required to view article.